Related Experiment Video

Updated: Aug 13, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
07:51

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography

Published on: September 22, 2011

[Plasma calcitonin gene-related peptide (CGRP) level in patients with essential hypertension]

X Y Shi1, Y Yang, Y T Zhao

  • 1Department of Cardiology, Navy General Hospital, Beijing.

Zhonghua Nei Ke Za Zhi
|October 1, 1990
PubMed

Insights

Low levels of calcitonin gene-related peptide (CGRP) are linked to essential hypertension. This study found lower CGRP in hypertensive patients, suggesting its role in hypertension development.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Neuropeptide Research

Background:

  • Calcitonin gene-related peptide (CGRP) is a potent vasodilator.
  • Essential hypertension (EH) is a common cardiovascular condition.
  • The role of CGRP in the pathophysiology of EH requires further investigation.

Purpose of the Study:

  • To investigate plasma levels of CGRP in patients with essential hypertension.
  • To explore the relationship between CGRP levels and hypertension severity.
  • To examine the correlation between CGRP and atrial natriuretic factor (ANF) in EH.

Main Methods:

  • Plasma CGRP levels were measured in 45 patients with essential hypertension and compared to normal subjects.
  • Plasma ANF levels were also assessed in EH patients.
  • Statistical analysis was performed to determine correlations and significance.

Main Results:

  • Plasma CGRP levels were significantly lower in patients with EH compared to normal subjects (P < 0.001).
  • Decreased plasma CGRP levels correlated with increased hypertension severity.
  • Plasma ANF levels were significantly elevated in EH patients (P < 0.01), with a negative correlation to CGRP (r = -0.3615, P < 0.02).

Conclusions:

  • Reduced plasma CGRP may play a crucial role in the pathogenesis of essential hypertension.
  • The interplay between CGRP and ANF warrants further study in hypertensive conditions.
  • CGRP deficiency could be a contributing factor to the development and severity of hypertension.

More Related Videos

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents08:39

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Published on: May 16, 2022

Detection and Quantification of Calcitonin Gene-Related Peptide (CGRP) in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay07:14

Detection and Quantification of Calcitonin Gene-Related Peptide (CGRP) in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Published on: June 16, 2023

Related Concept Videos

Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...